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Richard P. Cambria, MD,a Boston, Mass
Objectives: Recent reports have shown promising early results after endovascular revascularization (percutaneous translu-
minal angioplasty [PTA]/stent) of patients with peroneal artery-only runoff (PAOR), although the long-term durability
is unclear. This study evaluated long-term primary patency and limb salvage of PTA/stent in patients with single-vessel
runoff and critical limb ischemia to determine if the peroneal artery yields inferior results.
Methods: From January 2002 to December 2007, 1075 infrainguinal PTA/stent procedures were performed in 920
patients. The study cohort comprised 201 limbs in 187 patients with single-vessel runoff and critical limb ischemia. End
points included primary patency, assisted patency, limb salvage, and survival. Long-term outcomes were determined by
Kaplan-Meier life-table and multivariate Cox regression analyses.
Results: There were 104 PAOR and 97 limbs with single-vessel posterior or anterior tibial artery runoff (non-PAOR).
Median follow-up was 25 months (range, 0-75 months). PAOR patients tended to be older (77.36  0.92 vs 72.65 
1.18 years, P  .002) and were more likely to be taking clopidogrel at presentation (88% vs 76%; P  .04). There were
no statistically significant differences in 5-year primary patency (26%  6.8% vs 30%  7.6%; P  .79), assisted patency
(75%  8.8% vs 81%  7.0%; P  .77), limb salvage (74%  8.0% vs 75%  7.1%; P  .47), and survival (38%  7.7% vs
47%  6.6%; P  .99) between the PAOR and the non-PAOR groups, respectively. On Cox regression multivariate
analysis, total occlusions predicted decreased assisted patency (hazard ratio, 2.99; 95% confidence interval, 1.21-7.41;
P  .02), whereas younger age predicted poor limb salvage (hazard ratio, 0.97; 95% confidence interval, 0.94-0.99; P 
.04). PAOR was not an independent predictor of any outcome on multivariate analysis.
Conclusions: Patients with PAOR have similar long-term outcomes to patients with non-PAOR. Thus, infrainguinal
endovascular revascularization can be considered a first-line therapy for patients with PAOR and critical limb ischemia.
(J Vasc Surg 2011;53:1007-13.)
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oSeveral early series of open surgical revascularization to
the peroneal artery have shown inferior results when com-
pared with anterior or posterior tibial targets. Dardik et al1
reported a 20% decrease in the cumulative patency for
peroneal bypass compared with tibial reconstructions at 30
months. Similarly, Reichle et al2 found a 20% decrease in
the initial limb salvage (LS) rates for femoroperoneal vs
femorotibial bypasses. However, Kacoyanis et al3 showed
that increased institutional experience with peroneal artery
bypass translates to improved graft patency and LS rates.
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ultiple centers.4-6
Infrainguinal percutaneous transluminal angioplasty
PTA) with selective stenting (PTA/stent) is associated
ith low perioperative morbidity and mortality.7 Al-
hough surgical bypass grafting remains the gold stan-
ard for infrainguinal revascularization, the price of
ong-term patency is an increased procedural morbidity,
nd as many as 50% of patients have not returned to their
rebypass functional status by 6 months.8 The combina-
ion of a high-risk population and acceptable medium-
erm LS rates have led many to recommend PTA/stent
s first-line therapy in patients with chronic lower ex-
remity ischemia.9,10
It is no surprise that poor runoff has been associated
ith decreased patency and LS rates in the endovascular
iterature.11,12 To date, however, only one study has
xamined the effect of specific runoff vessel on the
utcomes of PTA/stent. Dosluoglu et al13 showed that
here was no statistically significant difference in the
2-month primary patency (PP) or LS of patients with
eroneal artery-only runoff compared with those with
nterior or posterior tibial single-vessel runoff. The goal
f this study was to determine the long-term outcomes
f infrainguinal PTA/stent in patients with single-vessel
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April 20111008 Abularrage et alrunoff and to determine if the peroneal artery yields
inferior results.
METHODS
The clinical protocol for this was approved by the
Institutional Review Board of the Massachusetts General
Hospital.
Patients. The study included all patients with infrain-
guinal arterial occlusive disease, critical limb ischemia, and
single-vessel runoff who were treated with PTA/stent be-
tween January 2002 and December 2007. The decision to
use PTA/stent as the first-line therapy was based on the
clinical examination, anatomic evaluation, and judgment of
the vascular surgeon involved. Patients were stratified into
two cohorts: the first consisted of patients with single-vessel
peroneal artery-only runoff (PAOR), and the second con-
sisted of patients with anterior tibial or posterior tibial
single-vessel runoff (non-PAOR).
The diagnosis of diabetes mellitus was determined from
the hospital records and confirmed by the current use of
oral hypoglycemic agents or insulin. Estimated glomerular
filtration rate (GFR) was calculated according to the Mod-
ification of Diet in Renal Disease Study.14 Chronic renal
insufficiency was defined as a GFR60 mL/min/1.73m2,
or chronic kidney disease stages 3 to 5.15 Patients were
considered to have a history of coronary artery disease even
if they had previously undergone revascularization with
coronary artery angioplasty or bypass grafting. Hyperten-
sion and congestive heart failure were determined from the
hospital records and confirmed by the use of appropriate
medications.
Individual limbs were counted separately for the PP,
AP, and LS calculations so that patients undergoing staged,
bilateral procedures were recorded and evaluated as two
entries. Individual patients were counted once for the sur-
vival estimates using the initial intervention date.
Exclusion criteria included aortoiliac endovascular re-
construction, atherectomy, cryoplasty, mechanical throm-
bectomy, extended thrombolysis or other adjunctive endo-
luminal procedures, interventions for failing bypasses, and
patients who presented with acute, critical limb ischemia
requiring emergent revascularization or a functionally un-
salvageable limb.
Demographic, preoperative, perioperative, and postop-
erative data, including clinical presentation according to
Rutherford classification,16 lesion anatomy according to
the TransAtlantic Inter Society Consensus (TASC) I and II
femoropopliteal and tibial systems,17,18 and follow-up
ankle-brachial indices (ABI), pulse volume recordings
(PVR), or both, were collected for each patient. A multi-
level intervention was defined as a femoropopliteal inter-
vention in conjunction with a tibial intervention. A multi-
vessel intervention was defined as a PTA/stent in more
than one named vessel.
Technique. Our infrainguinal interventional tech-
nique has been reported previously.19 In brief, all infrain-
guinal interventions were performed by a team of vascular
surgeons who satisfied the Massachusetts General Hospital tascular Center credentialing and Society for Vascular
urgery criteria for performance of endovascular proce-
ures. Selective angiography was performed under local
nesthesia and systemic heparin, with a target activated
lotting time of 200 to 250 seconds. Lesions were crossed
ndoluminally or subintimally with hydrophilic or platinum-
ipped wires, and angiography was performed to confirm
istal endoluminal location.
Balloon angioplasty was performed with an appropri-
tely sized balloon chosen to match the nondiseased artery
djacent to the lesion. Selective stenting was performed at
he discretion of the operator for residual stenosis 30%,
ow-limiting dissection, intimal flap, or acute occlusion.
ompletion angiography was performed to assess the tech-
ical result.
Lesion characteristics were determined by an examina-
ion of the procedure notes, and individual images were
eviewed when necessary. Lower extremity disease was
ategorized under both TASC I and II femoropopliteal and
ibial systems. Disease was also categorized by intervention
ocation and patency of the distal runoff vessels. A distal
unoff vessel was considered patent in the absence of an
cclusion from its origin to the ankle.
After the procedure, unless contraindicated, all patients
ere given a loading dose of clopidogrel (300 mg) and
aintained on 75 mg/d for 6 to 12 weeks. All patients not
urrently taking aspirin received 325 mg on the day of the
rocedure, which was continued indefinitely.
Postprocedural follow-up. Patients were evaluated
t 6 weeks in the outpatient setting with clinical examina-
ion, ABI, or PVR, or both, and then at 3- to 6-month
ntervals thereafter. Patency was determined according to
he Rutherford guidelines,16 and patients who had loss of
istal pulses, return of symptoms, or a change in ABI/PVR
ere imaged further with angiography, when clinically
ndicated. Follow-up also involved a review of all outpatient
linic visits and hospital admissions documented in our
ystem-wide electronic medical record.
Definitions and end points. A failure of PP included
return of symptoms in the face of worsening ABI and
ampened PVR due to recurrent disease. Assisted patency
AP) was achieved through secondary endovascular inter-
ention regardless of whether the recurrent lesion was a
tenosis, occlusion, or a new lesion in the same anatomic
egment. Patients requiring surgical bypass were not in-
luded in the AP calculations. LS included all major ampu-
ations (below knee and above knee). Minor amputations
digit, transmetatarsal) were not included in LS calcula-
ions. Survival data were obtained frommedical records and
he Social Security Database.
Statistical analysis. Patient demographic and risk fac-
or data associated with patency, and comparisons between
he two cohorts, were performed by fitting a generalized
inear model for each covariate of interest. To take into
ccount limb correlation because limbs were counted sep-
rately, standard error for inference was estimated using the
eneralized estimating equation method. P values to iden-
ify differences between groups were based on Wald tests.
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Volume 53, Number 4 Abularrage et al 1009PP, AP, and LS univariate analyses were performed
using Coxmodels with robust variance to take into account
the limb correlation. P values to identify differences be-
tween groups were based on Wald tests. Survival analysis
was performed using Kaplan-Meier life tables, withMantel-
Cox log-rank univariate analysis to identify differences be-
tween groups.
Hazards ratios (HRs) and 95% confidence intervals
(CIs) were determined using a multivariate Cox propor-
tional hazards model for data with variable follow-up. All
variables with P  .10 on univariate Cox analysis were
included in multivariate Cox regression analysis, and all P
values  .05 were considered significant. For PP, AP, and
LS end points, these models were fit with robust variance to
take into account the limb correlation.
RESULTS
A total of 1075 infrainguinal PTA/stent procedures
were performed in 920 patients during the study period.
From this population, infrainguinal endovascular interven-
tion was performed in 201 limbs of 187 patients with
single-vessel runoff and critical limb ischemia. There were
104 limbs (51.7%) with PAOR and 97 (48.3%) with ante-
rior tibial or posterior tibial artery single-vessel runoff (non-
PAOR). Significant clinical and demographic factors are
summarized in Table I. PAOR patients tended to be older
(77.36  0.92 vs 72.65  1.18 years; P  .002) and were
more likely to be taking clopidogrel at presentation (88% vs
76%; P  .04). There were no significant differences in
lesion characteristics between the two groups (Table II).
Median follow-up in the entire cohort was 25 months
(range, 0-75 months). In all patients with single-vessel
Table I. Demographics, clinical data, and anatomic data
Variable
PAOR
Single-vessel
non-PAOR
PNo. (%) No. (%)
Limbs, No. 104 97
Preoperative comorbidities
Age, yearsa 77.36  0.92 72.65  1.18 .002
Tobacco use 60 (58) 55 (57) .99
Male gender 58 (56) 56 (58) .89
Hypertension 98 (94) 88 (91) .16
Congestive heart failure 33 (32) 26 (27) .53
Coronary artery disease 66 (63) 63 (65) .99
Diabetes mellitus 72 (69) 70 (72) .76
Insulin-dependent 39 (38) 41 (42) .62
Non-insulin-dependent 33 (32) 29 (30) .62
Chronic renal insufficiency 74 (71) 62 (64) .29
Dialysis 12 (12) 16 (16) .42
Hypercholesterolemia 72 (69) 66 (68) .99
Medications
Clopidogrel 92 (88) 74 (76) .04
Beta-blocker 54 (52) 54 (56) .99
Statin 66 (63) 61 (63) .99
Warfarin 31 (30) 31 (32) .99
PAOR, Peroneal artery-only runoff.
aMean  standard error of the mean.runoff, the 1-, 3-, and 5-year PP rates were 61%  3.8%, F1%  4.6%, and 30%  5.1%, respectively. Univariate
nalysis demonstrated no significant differences in PP of
atients with PAOR compared with non-PAOR (P  .79;
ig 1. Kaplan-Meier curves show the primary patency (PP) of
atients with peroneal artery-only runoff (PAOR) and single-vessel
on-PAOR undergoing percutaneous transluminal angioplasty.
E, Standard error.
able II. Lesion characteristics and anatomic data
ariable
PAOR
Single-vessel
non-PAOR
PNo. (%) No. (%)
imbs, No. 104 97
esion characteristics
tenosis only 50 (48) 45 (46) .89
cclusion only 29 (28) 27 (28) .99
um lesion lengths, cma 7.74  0.62 6.81  0.67 .31
em-pop TASC I
IA 13 (13%) 13 (13%) .83
IB 21 (20) 23 (24) .47
IC 32 (31) 27 (28) .73
ID 3 (3) 0 (0) .25
em-pop TASC II
IIA 9 (9) 6 (6) .78
IIB 47 (45) 44 (45) .56
IIC 9 (9) 9 (9) .80
IID 3 (3) 0 (0) .25
ibial TASC
A 0 (0) 0 (0) . . .
B 0 (0) 0 (0) . . .
C 29 (28) 30 (31) .68
D 21 (20) 17 (18) .68
ntervention location
Isolated fem-pop 46 (44) 40 (41) .67
Isolated tibial 17 (16) 17 (18) .85
Multilevel 41 (39) 40 (41) .89
Multivessel 70 (67) 60 (62) .46
ntervention
Stent 27 (26) 23 (24) .75
AOR, Peroneal artery-only runoff; TASC,TransAtlantic InterSociety Con-
ensus.
Mean  standard error of the mean.ig 1), with 1-, 3-, and 5-year PP rates of 61%  5.2% vs
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vs 30%  7.6%, respectively (P  .79). None of the demo-
graphic, clinical, or anatomic factors examined were asso-
ciated with poor PP on univariate analysis (Table III).
There were 78 failures of the initial PTA/stent (42
PAOR, 36 non-PAOR). Eight of these patients were ob-
served (6 PAOR, 2 non-PAOR), 53 underwent a second
PTA/stent procedure (26 PAOR, 27 non-PAOR), 8 un-
derwent bypass (2 PAOR, 6 non-PAOR), and 9 underwent
immediate amputation (8 PAOR, 1 non-PAOR). Of the 53
patients who underwent a second PTA/stent, 6 ultimately
required surgical revascularization (4 PAOR, 2 non-
PAOR), of whom 3 eventually needed an amputation (2
PAOR, 1 non-PAOR).
In all patients with single-vessel runoff, the 1-, 3-, and
5-year AP rates were 94% 2.1%, 86% 3.4%, and 78%
5.4%, respectively. Univariate analysis showed no signifi-
Table III. Univariate analyses for primary patency, assisted
vessel runoff undergoing infrainguinal endovascular interve
Single-vessel runoff
Primary patency
(n  201)
Preoperative comorbidities
Age .21
Tobacco use .81
Male gender .39
Hypertension .24
Congestive heart failure .42
Coronary artery disease .50
Diabetes mellitus .57
Insulin-dependent .08
Non-insulin-dependent .08
Chronic renal insufficiency .61
Dialysis .35
Hypercholesterolemia .94
Lesion characteristics
Stenosis only .35
Occlusion only .08
Sum lesion lengths .93
Runoff
Single-vessel peroneal runoff .79
Femoropopliteal TASC I
IA/B vs C/D .77
Femoropopliteal TASC II
IIA/B vs C/D .75
Tibial TASC
C vs D .69
Intervention location
Isolated femoropopliteal .72
Isolated tibial .21
Multilevel .57
Multivessel .89
Intervention
Stent .34
Amputation
Any amputation . . .
Minor amputation . . .
Major amputation . . .
TASC, TransAtlantic InterSociety Consensus.cant differences in AP of patients with PAOR compared 7ith non-PAOR (P .77; Fig 2). The 1-, 3-, and 5-year AP
ates of patients with PAOR compared with non-PAOR
ere 94%  2.8% vs 94%  3.1%, 83%  5.1% vs 89% 
.3% and 75%  8.8% vs 81%  7.0%, respectively (P 
77). Factors associated with poor AP on univariate analysis
ncluded lesions that were only occlusions (Table III). On
ox proportional hazards multivariate analysis of patients
ith single-vessel runoff, occluded lesions were the only
ndependent predictor of decreased AP (HR, 2.99; 95%CI,
.21-7.41; P  .02).
In all patients with single-vessel runoff, the 1-, 3-,
nd 5-year LS rates were 87%  2.6%, 85%  2.9%, and
5%  5.5%, respectively. Univariate analysis found no
ignificant differences in LS of patients with PAOR com-
ared with non-PAOR (P  .47; Fig 3) with respective
S rates of 91%  3.1% vs 83%  4.2% at 1 year, 88% 
.7% vs 81% 4.7% at 3 years, and 74% 8.0% vs 75%
ency, limb salvage, and survival in patients with single-
n
P value
Assisted patency
(n  201)
Limb salvage
(n  201)
Survival
(n  187)
.14 .04 .0001
.86 .23 .15
.61 .14 .39
.39 .28 .37
.32 .48  .0001
.54 .28 .001
.62 .53 .56
.61 .89 .63
.61 .89 .63
.36 .93 .06
.17 .05 .002
.52 .99 .16
.32 .47 .19
.01 .91 .94
.85 .16 .53
.77 .47 .99
.41 .54 .10
.99 .95 .92
.06 .84 .88
.46 .74 .70
.57 .25 .01
.24 .23 .11
.63 .91 .007
.37 .10 .29
. . . . . . .66
. . . . . . .86
. . . . . . .70pat
ntio.1% at 5 years. The only univariate predictor of poor LS
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Volume 53, Number 4 Abularrage et al 1011was younger age (P  .04; Table III). On Cox propor-
tional hazards multivariate analysis of patients with single-
vessel runoff, younger age was the only independent pre-
dictor of decreased LS (HR, 0.97; 95% CI, 0.94-0.99; P
.04).
In all patients with single-vessel runoff, the 1-, 3-, and
5-year survival rates were 77%  3.1%, 59%  3.9%, and
43% 4.9%, respectively. On univariate analysis, there were
no significant differences in survival of patients with PAOR
compared with non-PAOR (P  .99; Fig 4), with survival
of 81%  4.0% vs 72  4.8% at 1 year, 56%  5.5% vs
63%  5.4% at 3 years, and 38%  7.7% vs 47%  6.6% at
5 years (P  .99). Factors associated with poor survival
included increasing age, congestive heart failure, coronary
artery disease, need for dialysis, an isolated tibial interven-
tion, and a multivessel intervention (Table III). Cox pro-
portional hazards multivariate analysis of patients with
single-vessel runoff found independent predictors of poor
survival were increasing age (HR, 1.05; 95% CI, 1.02-1.07;
P  .0007), coronary artery disease (HR, 1.89; 95% CI,
1.10-3.25; P  .02), multivessel intervention (HR, 1.94;
95% CI, 1.14-3.31; P .02), congestive heart failure (HR,
2.02; 95% CI, 1.28-3.21; P  .003), and need for dialysis
(HR, 2.67; 95% CI, 1.52-4.72; P  .0007).
DISCUSSION
To our knowledge, this is the largest study to date
examining the effect of single-vessel runoff on the long-
term outcomes of infrainguinal PTA/stent. The major
finding of this series was that patients with critical limb
ischemia and PAOR have similar long-term outcomes com-
pared with non-PAOR patients. Furthermore, patients
with critical limb ischemia and single-vessel runoff can
achieve excellent LS with close surveillance and aggressive
Fig 2. Kaplan-Meier curves show the assisted patency (AP) of
patients with peroneal artery-only runoff (PAOR) and single-vessel
non-PAOR undergoing percutaneous transluminal angioplasty.
SE, Standard error.reintervention. tOpen surgical revascularization using autogenous sa-
henous vein remains the gold standard for the treatment
f critical limb ischemia. Although early results of surgical
ypass to the peroneal artery were inferior to those using
ibial targets,1,2 several recent studies showed no difference
n patency or LS based on tibial runoff vessel. Sidawy et al5
emonstrated no significant differences between the 6-year
atency rates of bypasses to the peroneal artery compared
ith bypasses to the anterior or posterior tibial artery.
arling et al6 similarly showed no differences in the 5-year
atency of bypasses to the peroneal artery compared with
ig 3. Kaplan-Meier curves show limb salvage (LS) of patients
ith peroneal artery-only runoff (PAOR) and single-vessel non-
AOR undergoing percutaneous transluminal angioplasty. SE,
tandard error.
ig 4. Kaplan-Meier curves show survival of patients with per-
neal artery-only runoff (PAOR) and single-vessel non-PAOR
ndergoing percutaneous transluminal angioplasty. SE, Standard
rror.hose to the dorsalis pedis artery.
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April 20111012 Abularrage et alDespite excellent LS rates with open bypass, surgical
grafting is associated with local as well as systemic compli-
cations in up to 25% of patients.20,21 Of patients undergo-
ing open lower extremity bypass, 50% report a return to
normal functional status by 6 months, thus demonstrating
a high degree of morbidity associated with the procedure.22
Furthermore, we have shown that LS rates achieved with an
aggressive endovascular approach can be comparable to
those achieved with open bypass,23 and some authors have
concluded that PTA/stent should be used as a first-line
therapy in patients with chronic lower extremity ischemia.9
Although few studies have examined the effect of the
specific runoff vessel, many studies have examined the effect
of poor runoff on the outcomes of endovascular interven-
tions. Early results from our own institution found that
poor runoff was associated with a 3.7-fold increase in the
risk of early PTA failure.11 Davies et al24 demonstrated an
incremental decrease in cumulative patency of superficial
femoral endoluminal interventions in patients with worsen-
ing runoff. Finally, we previously reported that no or one-
vessel runoff independently predicts poor long-term PP in
patients undergoing infrageniculate interventions.25
In the only other study to examine the specific runoff
vessel, Dosluoglu et al13 found no significant difference in
the 12-month PP of patients with tissue loss and PAOR
compared with non-PAOR (73% 9% vs 74 % 12%, P
.668) nor when compared with those with more than
one-vessel runoff (73% 9% vs 77% 5%; P .150). This
is similar to the current study, in which the 5-year PP rates
were similar between the PAOR and non-PAOR groups.
However, we previously reported a decreased PP in
patients with PAOR compared with those with more than
single-vessel runoff and that PAOR was an independent
predictor of poor PP in all patients undergoing infraingui-
nal PTA/stent. The differences between the current study
and our previous study can likely be accounted for by the
fact that the previous study compared PAOR with all other
runoff, whereas the current study compares PAOR with
anterior tibial or posterior tibial single-vessel runoff. Thus,
the specific runoff vessel is not predictive of poor PP.
The current study found that there were no differences
in AP between the PAOR and non-PAOR groups. This
would suggest that despite a relatively poor long-term PP
of patients with single-vessel runoff undergoing infraingui-
nal PTA/stent, comparable long-term patency at 5 years
can be achieved with reintervention. Given that the 5-year
AP rate of 75% is similar to historical controls for open
peroneal artery bypass patency rates,5,6 single-vessel PAOR
in the context of critical limb ischemia should not be
considered a contraindication to endovascular revascular-
ization.
In addition, treated lesions that were only occlusions
and did not include any stenoses were the only independent
predictor of poor AP on Cox proportional hazards analysis
of patients with single-vessel runoff. On the basis of what is
known regarding the durability of PTA/stent for occlu-
sions vs stenoses, these results are not surprising.26,27How-
ever, why lesions that were only occlusions independently oredicted poor AP but TASC classification did not is un-
lear. It is possible that this anatomic variable was clinically
orse because it would take into account multilevel occlu-
ions, and we evaluated femoropopliteal TASC classifica-
ion separately from tibial TASC classification. The TASC
lassification may also inherently not be a significant pre-
ictor, because this is similar to our previously published
esults in which TASC classification was not predictive of
arly outcomes.11
Similar to Dosluoglu et al,13 we found no differences in
ong-term LS rates between the PAOR and non-PAOR
roups. Thus, the equivalent AP translated into compara-
le LS rates between the two groups. Furthermore,
ounger age was associated with poor LS in patients with
ingle-vessel runoff. To our knowledge, this association has
ot been reported previously and may represent a more
evere and aggressive disease pattern seen in these patients.
iven the results of the Bypass Versus Angioplasty in Severe
schaemia of the Leg (BASIL) trial, where surgical bypass
as recommended in patients with a predicted survival 2
ears, further studies are necessary to examine whether a
ypass-first strategy would be beneficial in these younger
atients with single-vessel runoff.28
Some have suggested that PAORmay be inadequate to
revent amputation in patients with single-vessel runoff
nd critical limb ischemia. Faglia et al29 found that no
mputations were performed in patients with non-PAOR,
ut 7 of 186 patients with PAOR required amputation.
hey concluded that patency of the peroneal artery is not as
ritical as patency of a tibial artery. The long-term out-
omes of the current report confirm previous short-term
esults that the peroneal artery is equivalent to single-vessel
ibial runoff in a patent an endovascularly treated arterial
egment.30 Furthermore, the long-term LS presented here
s similar to the 68% to 93% LS rates for open peroneal
rtery bypass reported in the literature.31-33
This study is a single-center, retrospective analysis and
s therefore limited by the potential for referral and selec-
ion bias. Furthermore, patency was determined by return
f symptoms and change in ABI/PVR due to its cost-
ffectiveness. Ideally, patency would be assessed with du-
lex ultrasound imaging or angiography in a prospective
anner, but this is not always practical in the clinical
etting.
ONCLUSIONS
As stated previously, open lower extremity revascular-
zation is associated with significant major morbidity and
ortality.10 Endovascular revascularization is less invasive
nd less morbid and has increasingly been used to treat
ore complex lesions in patients who frequently present
ith progressive disease.12 Although patients with PAOR
epresent a small percentage of the population, the current
tudy demonstrates that endovascular revascularization in
his group of patients can result in exceptional long-term
utcomes, despite a challenging anatomy.
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